NIH-funded research Fellowship grant

Creating new methods to change how proteins interact in the body

Official title: Development of evolutionary technologies to reprogram protein-protein interactions

Funded at University of Chicago · NIH-10975955 · Data updated 2026-11-12

This study is exploring new ways to change how proteins interact in the body, which could help create better treatments for tough-to-treat diseases, giving patients hope for more effective options.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startNovember 16, 2022
Project endNovember 15, 2025
Funding year2025
Award (this year)$76,756
NIH project number5F32GM147968-03
Project IDNIH-10975955 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with diseases linked to dysregulated protein-protein interactions, such as certain cancers.

Less likely to help

Patients with conditions unrelated to protein-protein interactions may not benefit from this research.

What this research studies

This research focuses on developing innovative technologies to alter protein-protein interactions (PPIs), which are crucial for many biological processes and disease states. By identifying and targeting these interactions, the project aims to create new therapeutic options for conditions that are currently difficult to treat. The approach involves using advanced techniques to quickly discover and validate molecular probes that can disrupt harmful PPIs, potentially leading to faster and more effective drug development. Patients may benefit from new treatments that target the underlying mechanisms of their diseases more effectively.

Why it matters

Potential benefit: If successful, this research could lead to the development of new therapies for diseases that are currently hard to treat due to challenging protein interactions.

How similar studies have gone: Other research has shown promise in targeting protein-protein interactions, indicating that this approach could lead to significant advancements in treatment options.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Styles, Matthew J — University of Chicago
  • Study coordinator: Styles, Matthew J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.